Histopathological assessment of anastrozole versus tamoxifen as preoperative treatment in postmenopausal women with T2–4b, N0–2, M0 breast cancer: Results from a randomized, double-blind study

Survival advantage of exemestane (EXE, Aromasin®) over megestrol acetate (MA) in postmenopausal women with advanced breast cancer (ABC) refractory to tamoxifen (TAM): results of a phase III randomized double-blind study

European Journal of Cancer ◽

10.1016/s0959-8049(99)80705-9 ◽

1999 ◽

Vol 35 ◽

pp. S84 ◽

Cited By ~ 2

Author(s):

E. Bajetta ◽

L.Y. Dirix ◽

L.E. Fein ◽

S.E. Jones ◽

J. Cervek ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Survival Advantage ◽

Advanced Breast ◽

Blind Study ◽

Megestrol Acetate ◽

Phase Iii ◽

Double Blind Study ◽

Abstract OT1-1-01: LORELEI: A Phase II randomized, double-blind study of neoadjuvant letrozole plus taselisib (GDC-0032) versus letrozole plus placebo in postmenopausal women with ER-positive/HER2-negative, early stage breast cancer

10.1158/1538-7445.sabcs14-ot1-1-01 ◽

2015 ◽

Author(s):

Cristina Saura ◽

Evandro de Azambuja ◽

Peter Dubsky ◽

Mafalda Oliveira ◽

Kamal S Saini ◽

...

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Early Stage ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Abstract PD5-04: Ki67 changes and PEPI score in the LORELEI trial: A phase II randomized, double-blind study of neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with ER-positive/HER2-negative early-stage breast cancer

10.1158/1538-7445.sabcs17-pd5-04 ◽

2018 ◽

Author(s):

E de Azambuja ◽

C Saura ◽

P Nuciforo ◽

S Frantal ◽

M Oliveira ◽

...

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Early Stage ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

LORELEI: A Phase II randomized, double-blind study of neoadjuvant letrozole plus taselisib (GDC-0032) versus letrozole plus placebo in postmenopausal women with ER-positive/HER2-negative, early-stage breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.tps613 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. TPS613-TPS613 ◽

Cited By ~ 2

Author(s):

Cristina Saura ◽

Evandro De Azambuja ◽

Mafalda Oliveira ◽

Peter Christian Dubsky ◽

Dimitrios Zardavas ◽

...

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Early Stage ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Abstract OT1-03-06: LORELEI: A phase II randomized, double-blind study of neoadjuvant letrozole plus taselisib (GDC-0032) versus letrozole plus placebo in postmenopausal women with ER-positive/ HER2-negative, early-stage breast cancer

10.1158/1538-7445.sabcs15-ot1-03-06 ◽

2016 ◽

Author(s):

M Oliveira ◽

E de Azambuja ◽

C Saura ◽

P Dubsky ◽

D Zardavas ◽

...

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Early Stage ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Faculty Opinions recommendation of Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958301.793464607 ◽

2012 ◽

Author(s):

Nancy Lin ◽

Ines Vaz-Luis

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Advanced Breast Cancer ◽

Bone Metastases ◽

Advanced Breast ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Pain Outcomes

Faculty Opinions recommendation of Aprepitant versus dexamethasone for preventing chemotherapy-induced delayed emesis in patients with breast cancer: a randomized double-blind study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718203590.793488506 ◽

2013 ◽

Author(s):

Ana Maria Gonzalez-Angulo

Keyword(s):

Breast Cancer ◽

Blind Study ◽

Double Blind Study ◽

Delayed Emesis ◽

Beetroot juice intake with different amounts of nitrate does not change aerobic exercise-mediated responses in heart rate variability in hypertensive postmenopausal women: A randomized, crossover and double-blind study

Journal of Exercise Science & Fitness ◽

10.1016/j.jesf.2020.12.001 ◽

2021 ◽

Vol 19 (2) ◽

pp. 104-110

Author(s):

Victor Hugo V. Carrijo ◽

Ana Luiza Amaral ◽

Igor M. Mariano ◽

Tállita Cristina F. de Souza ◽

Jaqueline P. Batista ◽

...

Keyword(s):

Heart Rate ◽

Heart Rate Variability ◽

Aerobic Exercise ◽

Postmenopausal Women ◽

Blind Study ◽

Double Blind Study ◽

Beetroot Juice ◽

Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17β-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study

Fertility and Sterility ◽

10.1016/j.fertnstert.2006.11.142 ◽

2007 ◽

Vol 88 (2) ◽

pp. 383-389 ◽

Cited By ~ 10

Author(s):

Camil Castelo-Branco ◽

Santiago Palacios ◽

Francisco Vázquez ◽

José Villero ◽

Javier Ferrer ◽

...

Keyword(s):

Postmenopausal Women ◽

Serum Lipid ◽

Blind Study ◽

Nasal Administration ◽

Fixed Dose ◽

Double Blind Study ◽

Double Blind ◽

17Β Estradiol ◽

Different Doses

PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study

British Journal of Cancer ◽

10.1038/s41416-018-0340-2 ◽

2018 ◽

Vol 120 (2) ◽

pp. 172-182 ◽

Cited By ~ 19

Author(s):

Mark D. Pegram ◽

Igor Bondarenko ◽

Marina Moreira Costa Zorzetto ◽

Sachin Hingmire ◽

Hirotaka Iwase ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Blind Study ◽

Double Blind Study ◽

Her2 Positive ◽